Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
16h
Africanews on MSNDRC faces setback in fight against mpox amid ongoing fighting in eastThe Africa Centres for Disease Control and Prevention said the country saw a 31 per cent increase in cases last week.
THE Catholic Church has suspended the use of holy water as part of its liturgy in efforts to stop the spread of the Mpox ...
More than 500 mpox patients have fled clinics in eastern Democratic Republic of Congo over the last month amid the current ...
Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...
The two confirmed infected individuals have symptoms such as rash, fever, and headache, as well as pain in the body and ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results